Related Experiment Video
Updated: Jun 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiorenal syndrome: still not a defined entity
Carlo Longhini1, Christian Molino, Fabio Fabbian
1Department of Clinical and Experimental Medicine, University Hospital, St. Anna, Corso Giovecca, 203, 44100, Ferrara, Italy.
Insights
Heart failure and kidney disease frequently coexist, worsening outcomes. Managing these cardiorenal patients requires tailored therapies focusing on volume, blood pressure, and renal health to improve survival.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Increasing incidence of heart failure and chronic renal failure due to aging population, interventional cardiology, obesity, and diabetes.
- Coexistence of heart failure and renal failure is frequent, with over half of heart failure patients experiencing renal impairment.
- Renal dysfunction in heart failure patients stems from intrinsic renal disease, hemodynamic issues, or both.
Purpose of the Study:
- To review the complex cardiorenal connection and management strategies for patients with coexisting heart and kidney failure.
- To highlight the multifactorial nature of cardiorenal syndrome beyond simple hemodynamic alterations.
- To emphasize the importance of tailored therapeutic approaches for cardiorenal patients.
Main Methods:
- Review of existing literature on cardiorenal interactions and patient management.
- Discussion of pathophysiological mechanisms including hemodynamic, neurohormonal, inflammatory, and anemia-related factors.
- Emphasis on clinical monitoring and management principles for cardiorenal patients.
Main Results:
- Cardiorenal interactions involve complex mechanisms beyond hemodynamics, including the renin-angiotensin system, oxidative stress, inflammation, anemia, and sympathetic nervous system.
- Renal dysfunction significantly worsens mortality in heart failure patients.
- Effective management requires a holistic approach addressing intravascular volume, blood pressure, renal hemodynamics, and anemia.
Conclusions:
- Management of cardiorenal patients necessitates individualized therapy to maintain patient equilibrium.
- Close monitoring of physical examination, weight, blood pressure, and laboratory values is crucial for early complication detection and prevention.
- Prioritizing management of intravascular volume, blood pressure, renal hemodynamics, and anemia is vital for improving survival in cardiorenal patients.
Abstract:
Because of the increasing incidence of cardiac failure and chronic renal failure due to the progressive aging of the population, the extensive application of cardiac interventional techniques, the rising rates of obesity and diabetes mellitus, coexistence of heart failure and renal failure in the same patient are frequent. More than half of subjects with heart failure had renal impairment, and mortality worsened incrementally across the range of renal dysfunctions. In patients with heart failure, renal dysfunction can result from intrinsic renal disease, hemodynamic abnormalities, or their combination. Severe pump failure leads to low cardiac output and hypotension, and neurohormonal activation produces both fluid retention and vasoconstriction. However, the cardiorenal connection is more elaborate than the hemodynamic model alone; effects of the renin-angiotensin system, the balance between nitric oxide and reactive oxygen species, inflammation, anemia and the sympathetic nervous system should be taken into account. The management of cardiorenal patients requires a tailored therapy that prioritizes the preservation of the equilibrium of each individual patient. Intravascular volume, blood pressure, renal hemodynamic, anemia and intrinsic renal disease management are crucial for improving patients' survival. Complications should be foreseen and prevented, looking carefully at basic physical examination, weight and blood pressure monitoring, and blood, urine urea and electrolytes measurement.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care